Related Experiment Video
Updated: Jul 26, 2026
12:49
Mutagenesis and Analysis of Genetic Mutations in the GC-rich KISS1 Receptor Sequence Identified in Humans with Reproductive Disorders
Published on: September 4, 2011
HPRT mutations in humans: biomarkers for mechanistic studies
1University of Vermont Genetic Toxicology Laboratory, 32 North Prospect Street, Burlington, VT 05401, USA. ralberti@zoo.uvm.edu
Mutation Research
|October 24, 2001
Summary
The hypoxanthine-guanine phosphoribosyltransferase (HPRT) gene acts as a reporter for somatic mutations in T cells. HPRT studies reveal insights into cellular processes, carcinogens, and immune responses.
Area of Science:
- Genetics
- Molecular Biology
- Immunology
Background:
- The X-chromosomal gene hypoxanthine-guanine phosphoribosyltransferase (HPRT) is crucial for DNA repair.
- Germinal mutations in HPRT were first identified in humans.
- HPRT serves as a valuable reporter gene for mutation studies.
Purpose of the Study:
- To explore the utility of HPRT as a reporter gene for somatic mutations.
- To investigate HPRT mutations in T cells for monitoring environmental mutagen exposure.
- To analyze HPRT mutations for understanding fundamental cellular and biological processes.
Main Methods:
- In vivo mutational studies focusing on peripheral blood lymphocytes.
- Analysis of molecular mutational spectra in T cells.
- Examination of HPRT mutant distributions among T cell receptor (TCR) gene-defined T cell clones.
Main Results:
- HPRT mutations in T cells are used to monitor human exposure to environmental mutagens.
- Unexpected clonality was observed in HPRT mutant T cell clones.
- HPRT mutations serve as markers for V(D)J recombinase activity and T cell proliferation.
Conclusions:
- HPRT mutations provide insights into mutagenic processes and carcinogenic potential.
- Somatic mutations in HPRT can act as surrogate markers for immunological T cell proliferation.
- HPRT is instrumental in discovering and studying mutator phenotypes and in vivo selection processes.
